Sage Therapeutics Inc (NAS:SAGE)
$ 11.13 0.46 (4.31%) Market Cap: 669.82 Mil Enterprise Value: -72.17 Mil PE Ratio: 0 PB Ratio: 0.95 GF Score: 46/100

SAGE Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 09, 2020 / 01:00PM GMT
Release Date Price: $36.47 (-3.87%)
Anne Marie Cook
Sage Therapeutics, Inc. - Senior VP, General Counsel & Secretary

Good morning, everyone. We're going to get started. My name is Anne Marie Cook, Senior Vice President, General Counsel and Secretary of Sage Therapeutics. It's my pleasure to welcome you to our 2020 Annual Meeting of Stockholders, which is being held virtually this year via the Internet.

We have stockholders attending today via the web portal and the 800 number -- and via the 800 number that we have provided. Also present today virtually are our directors, including our CEO, Jeff Jonas, and our other executive officers.

The purpose of this meeting is to take action on the matters described in our Proxy Statement. Jeff Jonas and other members of the leadership team will be giving a business update and a broader perspective at the Goldman Sachs 41st Annual Global Healthcare Conference tomorrow at 3:00 Eastern time. A live webcast of the presentation can be accessed on the Investor page of Sage's website at investor.sagerx.com. As always, if stockholders have any questions about the business, please call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot